Affinity Technologies, Inc. , a biotechnology company advancing early-stage diagnostics including CyPath® Lung, the Company's noninvasive test for lung cancer, today announced that the Australian ...

The Global Sepsis Diagnostics Market size, valued at USD 1,133.2 million in 2018, grew substantially to USD 1,790.9 million ...